Cargando…

No Influence of Dabigatran Anticoagulation on Hemorrhagic Transformation in an Experimental Model of Ischemic Stroke

BACKGROUND: Dabigatran etexilate (DE) is a new oral direct thrombin inhibitor. Clinical trials point towards a favourable risk-to-benefit profile of DE compared to warfarin. In this study, we evaluated whether hemorrhagic transformation (HT) occurs after experimental stroke under DE treatment as we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bohmann, Ferdinand, Mirceska, Ana, Pfeilschifter, Josef, Lindhoff-Last, Edelgard, Steinmetz, Helmuth, Foerch, Christian, Pfeilschifter, Waltraud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404053/ https://www.ncbi.nlm.nih.gov/pubmed/22911709 http://dx.doi.org/10.1371/journal.pone.0040804

Ejemplares similares

Warfarin Anticoagulation Exacerbates the Risk of Hemorrhagic Transformation after rt-PA Treatment in Experimental Stroke: Therapeutic Potential of PCC
por: Pfeilschifter, Waltraud, et al.
Publicado: (2011)

FTY720 Treatment in the Convalescence Period Improves Functional Recovery and Reduces Reactive Astrogliosis in Photothrombotic Stroke
por: Brunkhorst, Robert, et al.
Publicado: (2013)

Endovascular treatment for ischemic stroke with the drip-and-ship model—Insights from the German Stroke Registry
por: Schaefer, Jan Hendrik, et al.
Publicado: (2022)

Evaluation of Endovascular Treatment for Acute Basilar Occlusion in a State-Wide Prospective Stroke Registry
por: Gruber, Katharina, et al.
Publicado: (2021)

Measuring Patient Safety Climate in Acute Stroke Therapy
por: Bohmann, Ferdinand O., et al.
Publicado: (2021)

Simulation-based training improves patient safety climate in acute stroke care (STREAM)
por: Bohmann, Ferdinand O., et al.
Publicado: (2021)

Exploring Contraindications for Thrombolysis: Risk of Hemorrhagic Transformation and Neurological Deterioration after Thrombolysis in Mice with Recent Ischemic Stroke and Hyperglycemia
por: Gelhard, Sarah, et al.
Publicado: (2022)

Thrombolysis in a Stroke Patient on Dabigatran Anticoagulation: Case Report and Synopsis of Published Cases
por: Pfeilschifter, Waltraud, et al.
Publicado: (2013)

Adherence to oral anticoagulant therapy in secondary stroke prevention – impact of the novel oral anticoagulants
por: Luger, Sebastian, et al.
Publicado: (2015)

Coadministration of FTY720 and rt-PA in an experimental model of large hemispheric stroke–no influence on functional outcome and blood–brain barrier disruption
por: Cai, Aijia, et al.
Publicado: (2013)

Beta adrenoceptor blockade ameliorates impaired glucose tolerance and alterations of the cerebral ceramide metabolism in an experimental model of ischemic stroke
por: Luger, Sebastian, et al.
Publicado: (2018)

A Sphingosine 1-Phosphate Gradient Is Linked to the Cerebral Recruitment of T Helper and Regulatory T Helper Cells during Acute Ischemic Stroke
por: Lucaciu, Alexandra, et al.
Publicado: (2020)

Treatment with the immunomodulator FTY720 does not promote spontaneous bacterial infections after experimental stroke in mice
por: Pfeilschifter, Waltraud, et al.
Publicado: (2011)

Reduction of Ischemic Stroke Associated Disability in the Population: A State-Wide Stroke Registry Analysis over a Decade
por: Foerch, Christian, et al.
Publicado: (2022)

Blood Levels of Glial Fibrillary Acidic Protein (GFAP) in Patients with Neurological Diseases
por: Mayer, Christoph A., et al.
Publicado: (2013)

Treatment with FTY720 has no beneficial effects on short-term outcome in an experimental model of intracerebral hemorrhage
por: Schlunk, Frieder, et al.
Publicado: (2016)

Sphingosine 1-phosphate levels in cerebrospinal fluid after subarachnoid hemorrhage
por: Männer, Anika, et al.
Publicado: (2020)

Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registry
por: Pfeilschifter, Waltraud, et al.
Publicado: (2022)

New oral anticoagulants in patients with nonvalvular atrial fibrillation: a review of pharmacokinetics, safety, efficacy, quality of life, and cost effectiveness
por: Mani, Helen, et al.
Publicado: (2014)

Predictive Factors of Acute Symptomatic Seizures in Patients With Ischemic Stroke Due to Large Vessel Occlusion
por: Tako, Lisa Marie, et al.
Publicado: (2022)

Area postrema syndrome as frequent feature of Bickerstaff brainstem encephalitis
por: Zeiner, Pia S., et al.
Publicado: (2018)

Thromboembolic Antiphospholipid Syndrome (APS): Efficacy and Safety of Different Anticoagulants-Results of the APSantiCO Registry
por: Schulz, Annabel, et al.
Publicado: (2022)

Blood Pressure Lowering Decreases Intracerebral Hemorrhage Volume and Improves Behavioral Outcomes in Experimental Animals
por: Bohmann, Ferdinand O., et al.
Publicado: (2020)

Outcome after Thrombectomy of Acute M1 and Carotid-T Occlusions with Involvement of the Corticospinal Tract in Postinterventional Imaging
por: Reitz, Sarah Christina, et al.
Publicado: (2022)

Mechanical thrombectomy does not increase the risk of acute symptomatic seizures in patients with an ischaemic stroke: a propensity score matching study
por: Kohlhase, Konstantin, et al.
Publicado: (2022)

Correction to: Mechanical thrombectomy does not increase the risk of acute symptomatic seizures in patients with an ischaemic stroke: a propensity score matching study
por: Kohlhase, Konstantin, et al.
Publicado: (2022)

Implementation of stroke teams and simulation training shortened process times in a regional stroke network—A network-wide prospective trial
por: Tahtali, Damla, et al.
Publicado: (2017)

Main considerable factors for correct laboratory test interpretation under DOA treatment
por: Mani, Helen, et al.
Publicado: (2013)

Quality assurance data for regional drip-and-ship strategies- gearing up the transfer process
por: Boss, Erendira G., et al.
Publicado: (2021)

The S1P–S1PR Axis in Neurological Disorders—Insights into Current and Future Therapeutic Perspectives
por: Lucaciu, Alexandra, et al.
Publicado: (2020)

The perfect crime? CCSVI not leaving a trace in MS
por: Mayer, Christoph A, et al.
Publicado: (2011)

Divergence and Convergence of Sex‐Specific Time Trends in Ischemic Stroke: 10‐Year Analysis of a State‐Wide Registry in Germany
por: Schaefer, Jan Hendrik, et al.
Publicado: (2022)

Dysphagia assessment in ischemic stroke after mechanical thrombectomy: When and how?
por: Lapa, Sriramya, et al.
Publicado: (2022)

Reversal of Anticoagulation Effect of Dabigatran with Idarucizumab, for Thrombolysis in Acute Ischemic Stroke: Inimicus Inimico Amicus
por: Maramattom, Boby V., et al.
Publicado: (2019)

The APSANTICO Study: A Prospective Observational Study to Evaluate Antiphospholipid Antibody Profiles in Patients with Thromboembolic Antiphospholipid Syndrome (APS) after COVID-19 Infection and/or Vaccination
por: Ott, Olivia, et al.
Publicado: (2023)

Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report
por: Agosti, Sergio, et al.
Publicado: (2017)

Hemorrhagic Transformation of Ischemic Strokes
por: Kovács, Kitti Bernadett, et al.
Publicado: (2023)

Preanalytical Biases in the Measurement of Human Blood Sphingolipids
por: Brunkhorst, Robert, et al.
Publicado: (2018)

Fingolimod for the treatment of neurological diseases—state of play and future perspectives
por: Brunkhorst, Robert, et al.
Publicado: (2014)

Luftnot und Kauderwelsch
por: Meyer, Anjela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l0n15chb233oh8im24tkukpm23